A detailed history of Lipe & Dalton transactions in Medtronic PLC stock. As of the latest transaction made, Lipe & Dalton holds 13,720 shares of MDT stock, worth $1.18 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
13,720
Previous 13,770 0.36%
Holding current value
$1.18 Million
Previous $1.08 Million 13.93%
% of portfolio
0.62%
Previous 0.58%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$76.84 - $91.03 $3,842 - $4,551
-50 Reduced 0.36%
13,720 $1.24 Million
Q2 2024

Aug 02, 2024

BUY
$78.71 - $87.02 $55,884 - $61,784
710 Added 5.44%
13,770 $1.08 Million
Q1 2024

May 07, 2024

BUY
$82.84 - $88.09 $16,568 - $17,618
200 Added 1.56%
13,060 $1.14 Million
Q3 2023

Nov 03, 2023

BUY
$78.22 - $90.4 $78 - $90
1 Added 0.01%
12,860 $1.01 Million
Q2 2023

Jul 26, 2023

BUY
$79.47 - $91.38 $65,721 - $75,571
827 Added 6.87%
12,859 $1.13 Million
Q1 2023

May 02, 2023

SELL
$76.72 - $87.58 $24,857 - $28,375
-324 Reduced 2.62%
12,032 $970,000
Q4 2022

Feb 03, 2023

SELL
$76.18 - $87.74 $30,395 - $35,008
-399 Reduced 3.13%
12,356 $960,000
Q3 2022

Nov 07, 2022

BUY
$80.75 - $95.31 $88,986 - $105,031
1,102 Added 9.46%
12,755 $1.03 Million
Q2 2022

Aug 01, 2022

SELL
$87.4 - $113.09 $13,022 - $16,850
-149 Reduced 1.26%
11,653 $1.05 Million
Q1 2022

Apr 26, 2022

BUY
$100.58 - $112.38 $32,185 - $35,961
320 Added 2.79%
11,802 $1.31 Million
Q4 2021

Feb 01, 2022

BUY
$99.53 - $127.75 $597 - $766
6 Added 0.05%
11,482 $1.19 Million
Q3 2021

Nov 01, 2021

SELL
$122.75 - $135.17 $24,427 - $26,898
-199 Reduced 1.7%
11,476 $1.44 Million
Q2 2021

Aug 02, 2021

BUY
$118.19 - $131.5 $118 - $131
1 Added 0.01%
11,675 $1.45 Million
Q1 2021

Apr 30, 2021

SELL
$111.18 - $119.74 $24,904 - $26,821
-224 Reduced 1.88%
11,674 $1.38 Million
Q4 2020

Jan 29, 2021

BUY
$100.57 - $117.14 $10,157 - $11,831
101 Added 0.86%
11,898 $1.39 Million
Q3 2020

Oct 30, 2020

SELL
$90.13 - $108.78 $36,052 - $43,512
-400 Reduced 3.28%
11,797 $1.23 Million
Q2 2020

Aug 07, 2020

SELL
$84.11 - $103.33 $8,326 - $10,229
-99 Reduced 0.81%
12,197 $1.12 Million
Q1 2020

May 01, 2020

SELL
$72.92 - $121.3 $30,918 - $51,431
-424 Reduced 3.33%
12,296 $1.11 Million
Q4 2019

Jan 21, 2020

SELL
$104.49 - $114.54 $23,405 - $25,656
-224 Reduced 1.73%
12,720 $1.44 Million
Q3 2019

Nov 07, 2019

SELL
$98.02 - $111.18 $138,110 - $156,652
-1,409 Reduced 9.82%
12,944 $1.41 Million
Q2 2019

Jul 24, 2019

SELL
$84.15 - $99.38 $16,830 - $19,876
-200 Reduced 1.37%
14,353 $1.4 Million
Q1 2019

Apr 30, 2019

SELL
$82.45 - $93.79 $70,000 - $79,627
-849 Reduced 5.51%
14,553 $1.33 Million
Q4 2018

Feb 08, 2019

BUY
$85.8 - $99.49 $85 - $99
1 Added 0.01%
15,402 $1.4 Million
Q3 2018

Nov 05, 2018

BUY
$85.91 - $99.17 $8,676 - $10,016
101 Added 0.66%
15,401 $1.52 Million
Q2 2018

Aug 06, 2018

SELL
$77.48 - $87.83 $15,805 - $17,917
-204 Reduced 1.32%
15,300 $1.31 Million
Q1 2018

May 04, 2018

SELL
$76.55 - $87.26 $26,486 - $30,191
-346 Reduced 2.18%
15,504 $1.24 Million
Q4 2017

Feb 13, 2018

SELL
$76.93 - $83.5 $90,546 - $98,279
-1,177 Reduced 6.91%
15,850 $1.28 Million
Q3 2017

Nov 03, 2017

SELL
$77.71 - $84.6 $16,008 - $17,427
-206 Reduced 1.2%
17,027 $1.32 Million
Q2 2017

Aug 08, 2017

BUY
N/A
17,233
17,233 $1.53 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Lipe & Dalton Portfolio

Follow Lipe & Dalton and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lipe & Dalton, based on Form 13F filings with the SEC.

News

Stay updated on Lipe & Dalton with notifications on news.